KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scotts Miracle-Gro (SMG) Common Equity (2016 - 2025)

Scotts Miracle-Gro (SMG) has disclosed Common Equity for 17 consecutive years, with -$500.6 million as the latest value for Q4 2025.

  • Quarterly Common Equity fell 4.4% to -$500.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$500.6 million through Dec 2025, down 4.4% year-over-year, with the annual reading at -$357.5 million for FY2025, 8.47% up from the prior year.
  • Common Equity hit -$500.6 million in Q4 2025 for Scotts Miracle-Gro, down from -$357.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.1 billion in Q3 2021 to a low of -$500.6 million in Q4 2025.
  • Historically, Common Equity has averaged $153.4 million across 5 years, with a median of $59.5 million in 2022.
  • Biggest five-year swings in Common Equity: soared 44.16% in 2021 and later crashed 747.73% in 2023.
  • Year by year, Common Equity stood at $1.0 billion in 2021, then crashed by 94.13% to $59.5 million in 2022, then plummeted by 747.73% to -$385.4 million in 2023, then dropped by 24.42% to -$479.5 million in 2024, then decreased by 4.4% to -$500.6 million in 2025.
  • Business Quant data shows Common Equity for SMG at -$500.6 million in Q4 2025, -$357.5 million in Q3 2025, and -$170.9 million in Q2 2025.